Brown University
Providence, Rhode Island, 02912, United States
NCT Number: NCT05540067
The overall aim of this program of research is to improve the mental health of people who identify as LGBTQ+ by increasing their social support through a brief intervention. The purpose of the proposed project is to establish the effectiveness of our empirically-supported, brief acceptance-based behavioral therapy (ABBT). To achieve the specific aims, the investigators will conduct a fully-powered, randomized clinical trial (n=240) with two treatment arms: treatment-as-usual (TAU) vs. ABBT.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Phase 2
Providence, Rhode Island, 02912, United States
During the COVID-19 pandemic, up to 81% of adults in the United States experienced worsening mental health. A major cause was the social isolation triggered by the pandemic due to quarantining, loss of family or friends, and loss of work. For individuals who lost social connections or were unable to adapt to maintain their connections, social support decreased and loneliness worsened, putting them at much higher risk for anxiety and depressive symptoms.
Importantly, people who identify as LGBTQ+ have been particularly affected by the social isolation caused by the pandemic and were already at much higher risk of social isolation, loneliness, and mental illness, including suicidality, before the pandemic. The objective of this R01 fully-powered trial is to examine the effectiveness of a brief acceptance-based behavioral telehealth intervention (ABBT) to improve mental health during the COVID-19 pandemic by strengthening social support among LGBTQ+ individuals.
The aims of this proposal are: (1) to examine the effectiveness of ABBT in reducing mental health morbidity by conducting a fully-powered, RCT (n=240) of ABBT vs. Treatment-as-Usual; and, (2) to examine potential mediators and moderators of ABBT treatment effects. Primary outcomes will be anxiety and depressive symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the first session, the interventionist will introduce the concept of acceptance and its possible benefits in the context of life values and participant-identified challenges related to the COVID-19 pandemic, mental health, and social support. Interventionists will help participants identify potential challenges to acceptance. At the second session, participants will practice acceptance-based coping skills and a social support behavioral plan will be developed. These discussions will help the participant clarify how best to align their values with decisions on how to manage their mental health and social support in the context of the COVID-19 pandemic.
TAU includes brief mental health screening, consultation with providers, and referrals to psychotherapy and/or psychiatric medication.
Time frame: 39 weeks
The interviewer-rated HAM-A is a measure of anxiety symptom severity.
Time frame: 39 weeks
The interviewer-rated QIDS-C is a measure of depressive symptom severity.
Time frame: 39 weeks
The GAD-7 is a self-report measure of anxiety severity.
Time frame: 39 weeks
The PHQ-9 is a self-report measure of depression severity.
Brown University
Other
Improving Mental Health Among the LGBTQ+ Community Impacted by the COVID-19 Pandemic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04595084
Alcohol Drinking, Alcohol Use, Unspecified
Cambridge, Massachusetts, United States
View Trial DetailsNCT06119854
Anxiety, Anxiety Disorders
New York, United States
View Trial DetailsNCT04980326
Anxiety, Anxiety Disorders
Sant Boi de Llobregat, Barcelona, Spain
View Trial DetailsNCT04846790
Anxiety, Anxiety Disorders
Bethesda, Maryland, United States
View Trial Details